Advertisement
Free, independent economic & markets data — verified from official sources (World Bank · IMF · OECD · NRB).
NepseTradingENनेपाली
Italy · Health expenditure

Italy Health expenditure

The World Bank — World Development Indicators (CC BY 4.0) · updated 2024-12-31

Latest · 20248.44%
Previous · 20238.41%
Highest · 20209.56%
Lowest · 20007.55%

Italy's health expenditure stands at 8.44% as of 2024-12-31, up from 8.41% in 2023. Historical data runs from 2000 to 2024 (25 observations).

Recent trend

In 2024, Italy's health expenditure was 8.44%, up from 8.41% in 2023.

In 2023, Italy's health expenditure was 8.41%, down from 8.85% in 2022.

In 2022, Italy's health expenditure was 8.85%, down from 9.28% in 2021.

In 2021, Italy's health expenditure was 9.28%, down from 9.56% in 2020.

In 2020, Italy's health expenditure was 9.56%, up from 8.62% in 2019.

Italy Health expenditure — historical data

YearValueChange
20248.44%+0.0388%
20238.41%-0.4446%
20228.85%-0.4314%
20219.28%-0.2827%
20209.56%+0.9489%
20198.62%-0.0393%
20188.65%-0.0359%
20178.69%-0.0298%
20168.72%-0.1255%
20158.85%-0.0132%
20148.86%+0.0694%
20138.79%-0.0086%
20128.8%+0.0698%
20118.73%-0.1508%
20108.88%-0.0336%
20098.91%+0.4113%
20088.5%+0.3999%
20078.1%-0.2962%
20068.4%+0.0888%
20058.31%+0.1718%
20048.14%+0.3306%
20037.81%-0.0297%
20027.84%+0.1252%
20017.71%+0.1641%
20007.55%

The World Bank — World Development Indicators (CC BY 4.0) · Download this series as CSV — free, attribution required (CC BY 4.0).

More Italy data

Frequently asked questions

What is Italy's health expenditure?

Italy's health expenditure is 8.44% as of 2024-12-31, compared with 8.41% in 2023. The World Bank — World Development Indicators (CC BY 4.0)

What was the highest health expenditure in Italy?

The highest recorded value is 9.56% (2020); the lowest is 7.55% (2000), across data from 2000 to 2024.

Where does this data come from?

The World Bank — World Development Indicators (CC BY 4.0) Figures are republished with attribution and updated as the source releases new observations.